Skip to main content
Premium Trial:

Request an Annual Quote

David Urdal, Mark Gabrielson, Stephen Blose, Klaas Kok

Premium
Gene Logic has added David Urdal and Mark Gabrielson to its board of directors, while Jules Blake has retired from the board, the company said last week.
 
Urdal is currently senior vice president and CSO at Dendreon. Previously he was president of Immunex.
 
Gabrielson is co-founder, director, and CEO of Pulmatrix, and has held posts at SmithKline Beecham and Prince Ventures.
 
Blake has been a board director at Gene Logic since 1994.
 

 
Stephen Blose has been elected to be chairman of BioMicro Systems, the company said last week. Blose has been a member of BioMicro’s board for three years.
 
Blose is CEO of Mill Valley Summit Group, which offers services and consulting for venture capital firms and life science companies.
 
Blose also has been a division general manager at Bio-Rad, working on commercializing DNA, informatics, and other systems. Before that he was president and CEO of Protein Databases.
 

 
Agilent Technologies announced last week that Klaas Kok has won 50 free microarrays in its microarray contest on the basis of his research. Kok is a professor in the department of genetics at the University Medical Center Groningen in the Netherlands.
 
Kok’s contest entry combined array-based comparative genomic hybridization with traditional gene-expression profiling in the search for novel tumor suppressor genes implicated in conventional renal cell carcinoma. Nearly 100 teams entered the contest, which ran from November 2006 through January 2007, Agilent said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.